Enhancing the efficacy of pneumococcal vaccination using a probiotic adjuvant

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This study will examine the ability of probiotics to enhance the human immune system response of infants immunised with the pneumococcal conjugate vaccine. Probiotics able to improve the immune system would provide greater protection against pneumococcal disease, a major cause of childhood illness and death of Indigenous Australians and among the developing world.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2014

Funding Scheme: Early Career Fellowships

Funding Amount: $302,123.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Preventive Medicine

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

child | infectious diseases | pneumococcal disease | prevention | preventive health | vaccination